Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Ritter

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomyGordon W Wong, Kerrin L Palazzi-Churas, David F Jarrard, et al.
Cancer|June 10, 2011
Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrenceTim J Kruser, David F Jarrard, Andrew K Graf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 13, 2016
Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancerJeffrey V Brower, Jeffrey D Forman, Patrick A Kupelian, et al.
American Journal of Clinical Oncology|July 18, 2019
Cardiac Toxicity in Operable Esophageal Cancer Patients Treated With or Without ChemoradiationJacob S Witt, Justin C Jagodinsky, Yifei Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 7, 2006
Integral radiation dose to normal structures with conformal external beam radiationHidefumi Aoyama, David Clark Westerly, Thomas Rockwell Mackie, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatmentsLeah K Schubert, David C Westerly, Wolfgang A Tomé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02Li Yan Khor, Jennifer Moughan, Tahseen Al-Saleem, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2025
Severe Late Toxicities (Grade 3-5) with 13 Years of Follow-up after Hypofractionated Postprostatectomy RadiotherapyKaili Ranta, Andrzej P Wojcieszynski, Shuang G Zhao, et al.
Cancer|May 21, 2016
Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockersZachary S Morris, Sandeep Saha, William J Magnuson, et al.
The Lancet. Oncology|September 21, 2007
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trialLi-Yan Khor, Kyounghwa Bae, Alan Pollack, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomyGordon W Wong, Kerrin L Palazzi-Churas, David F Jarrard, et al.
Cancer|June 10, 2011
Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrenceTim J Kruser, David F Jarrard, Andrew K Graf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 13, 2016
Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancerJeffrey V Brower, Jeffrey D Forman, Patrick A Kupelian, et al.
American Journal of Clinical Oncology|July 18, 2019
Cardiac Toxicity in Operable Esophageal Cancer Patients Treated With or Without ChemoradiationJacob S Witt, Justin C Jagodinsky, Yifei Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 7, 2006
Integral radiation dose to normal structures with conformal external beam radiationHidefumi Aoyama, David Clark Westerly, Thomas Rockwell Mackie, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatmentsLeah K Schubert, David C Westerly, Wolfgang A Tomé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02Li Yan Khor, Jennifer Moughan, Tahseen Al-Saleem, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2025
Severe Late Toxicities (Grade 3-5) with 13 Years of Follow-up after Hypofractionated Postprostatectomy RadiotherapyKaili Ranta, Andrzej P Wojcieszynski, Shuang G Zhao, et al.
Cancer|May 21, 2016
Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockersZachary S Morris, Sandeep Saha, William J Magnuson, et al.
The Lancet. Oncology|September 21, 2007
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trialLi-Yan Khor, Kyounghwa Bae, Alan Pollack, et al.
Pageof 4